Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class ASSE: 600329

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Semi-annual Report for 2026

Aug 15, 2026 · Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Routine Related Party TransactionsAug 8
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Obtaining Drug Registration Certificate by a BranchAug 7
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Results of Shareholding Increase in S Shares by Controlling ShareholderAug 5
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Aug 1

All Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news releases